ALMAC PHARMACEUTICALS GROUP (IRELAND) LIMITED

Almac Pharmaceuticals Group (Ireland) Limited is a globally-recognised life-science organisation that delivers end-to-end expertise across the entire drug-development lifecycle. With more than 7,800 employees worldwide, Almac partners with the top 25 biopharma companies to help bring innovative medicines from early discovery through to commercial launch, underpinned by a simple promise: "We will be exceptional, always."

The group's portfolio spans several specialised divisions. Almac Discovery focuses on first-in-class pre-clinical assets, employing cutting-edge research techniques to generate novel therapeutics. Almac Diagnostic Services provides precision-medicine solutions, including genomic services, biomarker development and clinical testing such as the PNPLA3 genotyping kit and single-cell sequencing. Almac Pharmaceutical Development & Manufacturing Services offers API manufacture, formulation development, clinical-trial supply and cold-chain capabilities, highlighted by a recent £65 million commercial manufacturing facility. Through its Galen brand, Almac also markets medicines globally and collaborates with like-minded partners.

Based in Ireland and operating a network of facilities worldwide, Almac has contributed to roughly 50 % of approved new molecular entities over the past six years, surpassed £1 billion in revenue, and earned accolades for innovation and sustainability. Its long-term client relationships and continual investment in technology and climate action make Almac a trusted partner in advancing human health.